Selected Publications

Borcherding N, Crotts SB, Ortolan LS, Henderson N, Bormann NL, Jabbari A. "A transcriptomic map of murine and human alopecia areata." JCI Insight 5:134724, 2020.

Ortolan LS, Kim SR, Crotts S, Liu LY, Craiglow BG, Wambier C, Paschoal RS, King BA, Jabbari A. "IL-12/IL-23 neutralization is ineffective for alopecia areata in mice and humans." J Allergy Clin Immunol 144:1731, 2019.

Borcherding N, Voigt AP, Liu V, Link BK, Zhang W, Jabbari A. "Single-cell profiling of cutaneous T-cell lymphoma reveals underlying heterogeneity associated with disease progression." Clin Cancer Res 15:2996, 2019.

de Jong A, Jabbari A, Dai Z, Xing L, Lee D, Li MM, Duvic M, Hordinsky M, Norris DA, Price V, Mackay-Wiggan J, Clynes R, Christiano AM.  "High-throughput T cell receptor sequencing identifies clonally expanded CD8+ T cell populations in alopecia areata." JCI Insight 3:e121949, 2018.

Mackay-Wiggan J*,  Jabbari A* , Nguyen N, Cerise JE, Clark C, Ulerio G, Furniss M, Vaughan R, Christiano AM*, Clynes R*. “Oral ruxolitinib induces hair regrowth in patients with moderate-to-severe alopecia areata.” JCI Insight 1: e89790, 2016. [* contributed equally]

Dai Z, Xing L, Cerise J, Wang EH, Jabbari A, de Jong A, Petukhova L, Christiano AM, Clynes R. “CXCR3 blockade inhibits T cell migration into the skin and prevents development of alopecia areata.” J Immunol 197:1089, 2016.

Jabbari A, Cerise JE, Chen JC, Mackay-Wiggan J, Duvic M, Price V, Hordinsky M, Norris D, Clynes R, Christiano AM. “Molecular signatures define alopecia areata subtypes and transcriptional biomarkers.” EBioMedicine, 7:240, 2016.

Chan ES, Herlitz L, Jabbari A.  “Ruxolitinib attenuates cutaneous lupus development in a mouse lupus model.”  J Invest Dermatol, 135:1912, 2015.

Jabbari A*, Dai Z*, Xing L*, Cerise JE, Ramot Y, Berkun Y, Montealegre Sanchez GA, Goldbach-Mansky R, Christiano AM, Clynes R, Zlotogorski A. “Reversal of alopecia areata following treatment with the JAK1/2 inhibitor baricitinib.” EBioMedicine, 2:351, 2015. [* contributed equally] 

Xing L*, Dai Z*, Jabbari A*, Cerise JE, Higgins C, Gong W, de Jong A, Harel, S, DeStefano GM, Rothman L, Singh P, Petukhova L, Mackay-Wiggan J, Christiano AM, Clynes R. “Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition.”  Nature Medicine, 20:1043, 2014. Cited in Nature Medicine News and Views: doi:10.1038/nm.3685. Cited in F1000Prime: F1000Prime.com/718535351. [* first authors, contributed equally]  

Jabbari A, Suarez-Farinas M, Fuentes-Duculan J, Gonzalez J, Cueto I, Franks Jr. AG, Krueger JG. “Dominant Th1 and minimal Th17 skewing in discoid lupus revealed by transcriptomic comparison with psoriasis.” J Invest Dermatol, 134: 87, 2014. Highlighted in Clinical Snippets: doi:10.1038/jid.2013.454. Cited in F1000Prime: F1000Prime.com/718025941.

Jabbari A, Petukhova L, Cabral RM, Clynes RC, Christiano AM. “Genetic basis of alopecia areata, a roadmap for translational research.”  Dermatol Clin, 31:109, 2013.

Jabbari A*, Suarez-Farinas M*, Dewell S, Krueger JG.  “Transcriptomic profiling of psoriasis using RNA-seq reveals previously unidentified differentially expressed genes.” J Invest Dermatol, 132:246, 2012. [* contributed equally] 

 

A more complete list of publications can be found here.